These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10568542)

  • 1. Review and critical analysis of available in vitro dissolution tests.
    Ansoborlo E; Hengé-Napoli MH; Chazel V; Gibert R; Guilmette RA
    Health Phys; 1999 Dec; 77(6):638-45. PubMed ID: 10568542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro chemical and cellular tests applied to uranium trioxide with different hydration states.
    Ansoborlo E; Chalabreysse J; Hengé-Napoli MH; Pujol E
    Environ Health Perspect; 1992 Jul; 97():139-43. PubMed ID: 1396449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro dissolution of uranium oxide by baboon alveolar macrophages.
    Poncy JL; Metivier H; Dhilly M; Verry M; Masse R
    Environ Health Perspect; 1992 Jul; 97():127-30. PubMed ID: 1396447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of dose-rate on risk from internally-deposited radionuclides and the potential need to separate dose-rate effectiveness factor (DREF) from the dose and dose-rate effectiveness factor (DDREF).
    Brooks AL; Eberlein PE; Couch LA; Boecker BB
    Health Phys; 2009 Nov; 97(5):458-69. PubMed ID: 19820455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetry of metal tritide particles as evaluated by the ICRP 66 model and a biokinetic model from laboratory rats.
    Zhou Y; Cheng YS
    Health Phys; 2004 Feb; 86(2):155-60. PubMed ID: 14744049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assessment of doses and effects from intakes of radioactive particles.
    Harrison JD; Stather JW
    J Anat; 1996 Dec; 189 ( Pt 3)(Pt 3):521-30. PubMed ID: 8982826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro solubility of uranium tetrafluoride with oxidizing medium compared with in vivo solubility in rats.
    Ansoborlo E; Chalabreysse J; Escallon S; Hengé-Napoli MH
    Int J Radiat Biol; 1990 Oct; 58(4):681-9. PubMed ID: 1976728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro dissolution studies of uranium bearing material in simulated lung fluid.
    Sdraulig S; Franich R; Tinker RA; Solomon S; O'Brien R; Johnston PN
    J Environ Radioact; 2008 Mar; 99(3):527-38. PubMed ID: 17949865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose estimate of inhaled hafnium tritide using the ICRP 66 lung model.
    Cheng YS; Zhou Y; Wang YS; Inkret WC; Wermer JR
    Health Phys; 2002 Jun; 82(6):817-24. PubMed ID: 12046753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is measurement of transportability class of inhaled material by in vitro dissolution satisfactory?
    Carter MW
    Health Phys; 1995 Oct; 69(4):549-52. PubMed ID: 7558847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of absorption parameters on calculation of the dose coefficient: example of classification of industrial uranium compounds.
    Chazel V; Houpert P; Paquet F; Ansoborlo E
    Radiat Prot Dosimetry; 2001; 94(3):261-8. PubMed ID: 11487809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung dissolution of uranium tetrafluoride in rats and baboons. Comparison with dissolution by alveolar macrophages in culture and chemical dissolution.
    André S; Métivier H; Auget D; Lantenois G; Boyer M; Masse R
    Hum Toxicol; 1989 Mar; 8(2):111-9. PubMed ID: 2744773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of airway retention for radiation doses from inhaled radionuclides.
    Bailey MR; Dorrian MD; Birchall A
    J Aerosol Med; 1995; 8(4):373-90. PubMed ID: 10172643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-dependent doses to members of the public from intake of radionuclides: Part 5. Compilation of ingestion and inhalation dose coefficients.
    Ann ICRP; 1996; 26(1):1-91. PubMed ID: 8886253
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of solubility on inhaled uranium compound clearance: a review.
    Eidson AF
    Health Phys; 1994 Jul; 67(1):1-14. PubMed ID: 8200796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new model for the human alimentary tract: the work of a Committee 2 task group.
    Métivier H;
    Radiat Prot Dosimetry; 2003; 105(1-4):43-8. PubMed ID: 14526925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of in vitro dissolution of aerosol particles for comparison to in vivo dissolution in the lower respiratory tract after inhalation.
    Kanapilly GM; Raabe OG; Goh CH; Chimenti RA
    Health Phys; 1973 May; 24(5):497-507. PubMed ID: 4707664
    [No Abstract]   [Full Text] [Related]  

  • 18. Searching for physiologically relevant in vitro dissolution techniques for orally inhaled drugs.
    Radivojev S; Zellnitz S; Paudel A; Fröhlich E
    Int J Pharm; 2019 Feb; 556():45-56. PubMed ID: 30529665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubility of hot fuel particles from Chernobyl--influencing parameters for individual radiation dose calculations.
    Garger EK; Meisenberg O; Odintsov O; Shynkarenko V; Tschiersch J
    Talanta; 2013 Oct; 115():40-6. PubMed ID: 24054559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of physico-chemical and biokinetic properties of uranium peroxide hydrate UO4.
    Ansoborlo E; Chazel V; Houpert P; Hengé-Napoli MH; Paquet F; Hodgson A; Stradling N
    Health Phys; 1998 Oct; 75(4):389-97. PubMed ID: 9753362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.